Pico-Salax Colonic Preparation Study: Quantifying Electrolyte and Volume Status Changes

Twenty adult volunteers will be administered Pico-Salax in the usual fashion for colonoscopy with intense monitoring of serum and urine chemistry and hemodynamics.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hemodynamics Hyponatremia Metabolic Diseases Nutritional and Metabolic Diseases Water-Electrolyte Imbalance

Age range

45 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Hotel Dieu Hospital

Kingston, Ontario, K7L5G2, Canada

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

healthy volunteers older than 45

Exclusion criteria

impaired renal function
congestive heart failure ascites known electrolyte abnormalities

Treatment and study plan

Pico-Salax

Drug

Two sachets of Pico-Salax given 5 hours apart

Primary outcomes

serum electrolytes

Time frame: 48 hours
patient hemodynamics

Time frame: 48 hours

Sponsors and collaborators

Lead sponsor

Queen's University

Other

Collaborators

Ferring Pharmaceuticals

Registry information

Important dates

Study start: 2008
Primary completion: 2008
Study completion: 2008
First posted: Apr 22, 2009
Registry last updated: Sep 22, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed